Chong Hua Hospital is dedicated to achieving its mission to provide excellent patient-centered care with state-of the art equipment, as well as advanced high-quality services in the Visayas region.
Likewise in February 2024, the hospital launched yet another first in the Viz-Min region: the Gallium-68 PSMA PET-CT scan. This service provides a highly sensitive and specific diagnostic imaging for prostate cancer. Moreover, with the availability of these target-specific molecular scans in Chong Hua Hospital, determining the suitability of patients for targeted radionuclide therapies are also made easier and possible. Hence, offered together with their new PET-CT imaging services, are their new Peptide Receptor Radionuclide Therapies , the Lutetium-177 DOTATATE for treatment of neuroendocrine tumors and Lutetium-177 PSMA for treatment of prostate cancer, respectively.